Dover, Delaware

A biotech company that uses AI to decode small RNA (sRNA) isoforms and develop biomarker-guided precision oligonucleotide therapeutics, with a focus on identifying disease-associated isoforms and designing therapeutics to counteract their effects. 

WITH CLARITAS SINCE

September 2022

KEY CLARITAS CONTACTS

John Chadwick

Managing Partner and CEO